SynthesisJournal of neuropathology and experimental neurology2025

MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature review.

Antonio Dono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.